- Home
- HRTX vs RCMT Comparison
HRTX vs RCMT Comparison
Compare HRTX & RCMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- RCMT
- Stock Information
- Founded
- HRTX 1983
- RCMT 1971
- Country
- HRTX United States
- RCMT United States
- Employees
- HRTX N/A
- RCMT N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- RCMT Professional Services
- Sector
- HRTX Health Care
- RCMT Consumer Discretionary
- Exchange
- HRTX Nasdaq
- RCMT Nasdaq
- Market Cap
- HRTX 242.0M
- RCMT 200.2M
- IPO Year
- HRTX 1987
- RCMT N/A
- Fundamental
- Price
- HRTX $1.19
- RCMT $22.62
- Analyst Decision
- HRTX Strong Buy
- RCMT Strong Buy
- Analyst Count
- HRTX 2
- RCMT 2
- Target Price
- HRTX $4.50
- RCMT $33.50
- AVG Volume (30 Days)
- HRTX 1.5M
- RCMT 31.2K
- Earning Date
- HRTX 11-04-2025
- RCMT 11-05-2025
- Dividend Yield
- HRTX N/A
- RCMT N/A
- EPS Growth
- HRTX N/A
- RCMT N/A
- EPS
- HRTX N/A
- RCMT 1.76
- Revenue
- HRTX $149,694,000.00
- RCMT $299,916,000.00
- Revenue This Year
- HRTX $10.62
- RCMT $15.03
- Revenue Next Year
- HRTX $12.99
- RCMT $7.49
- P/E Ratio
- HRTX N/A
- RCMT $12.83
- Revenue Growth
- HRTX 9.78
- RCMT 11.01
- 52 Week Low
- HRTX $1.04
- RCMT $13.18
- 52 Week High
- HRTX $2.68
- RCMT $28.27
- Technical
- Relative Strength Index (RSI)
- HRTX 39.59
- RCMT 36.23
- Support Level
- HRTX $1.16
- RCMT $21.47
- Resistance Level
- HRTX $1.25
- RCMT $23.67
- Average True Range (ATR)
- HRTX 0.07
- RCMT 0.86
- MACD
- HRTX -0.01
- RCMT -0.03
- Stochastic Oscillator
- HRTX 13.64
- RCMT 37.22
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.